NCT06638424

Brief Summary

Diabetes is one of the most common fatal metabolic diseases in the world. Diabetes-induced ocular surface alterations are poorly understood. Indeed, it was once thought that the cornea, avascular, was immune to the effects of diabetes. A growing number of publications now demonstrate the opposite. These alterations affect up to 70% of diabetic patients at some point in the progression of their diabetes. Another common complication of diabetes is the early development of a cataract, requiring surgery. Diabetic patients are therefore more likely to require surgery at an early age than the general population. Diabetes and cataract surgery both induce corneal changes. Cataract surgery in diabetic patients is therefore at greater risk of corneal complications. Diabetes induces dysfunction of the main lacrimal gland, corneal neuropathy, meibomian dysfunction and a decrease in conjunctival mucus cells. Diabetic patients are therefore particularly at risk of exacerbation or appearance of alterations of the corneal epithelium and the ocular surface in postoperative cataract surgery. Therefore, it seems necessary to evaluate the impact of cataract surgery on the ocular surface and corneal epithelium of diabetic patients, in order to improve their management.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 22, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 9, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 22, 2025

Completed
Last Updated

October 15, 2024

Status Verified

October 1, 2024

Enrollment Period

11 months

First QC Date

October 9, 2024

Last Update Submit

October 9, 2024

Conditions

Keywords

CataractDiabetesCorneal epitheliumLacrimal glandCorneal neuropathyMeibomian dysfunction

Outcome Measures

Primary Outcomes (1)

  • To assess whether cataract surgery induces an increased risk of corneal epithelial alterations in diabetic patients

    The six Oxford scheme grades (0-5), which denote the severity of dry eye, are used to record the results: * Stage 0 or 1: Mild * Stage 2 or 3: Moderate * Stage 4 or 5: Severe

    One month before and one month after surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patient (≥18 years) operated on for cataract at HUS between January 2022 and January 2024;

You may qualify if:

  • Adult patient (≥18 years);
  • Patient operated on for cataract at HUS between January 2022 and January 2024;
  • Patient who did not express his opposition to the reuse of his data for scientific research purposes;
  • Patient who benefited from the measurement of the above-mentioned judgment criteria during his pre- and post-operative consultations.

You may not qualify if:

  • Presence in the medical file of the subject's opposition to the reuse of his data for scientific research purposes.
  • Prolonged use of stored eye drops;
  • Documented etiology of chronic alteration of the ocular surface (shingles, herpes, Gougerot-Sjogren syndrome, graft-versus-host disease);
  • Minor patient or under guardianship or curatorship.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service d'Ophtalmologie - CHU de Strasbourg - France

Strasbourg, 67091, France

RECRUITING

Related Publications (1)

  • Koestel E, Dormegny L, Sauer A, Gaucher D, Bourcier T. Ocular surface changes and corneal epithelial remodeling after cataract surgery in patients with type 2 diabetes: a case-control study. BMC Ophthalmol. 2025 Jul 1;25(1):355. doi: 10.1186/s12886-025-04178-6.

MeSH Terms

Conditions

CataractDiabetes Mellitus

Condition Hierarchy (Ancestors)

Lens DiseasesEye DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 9, 2024

First Posted

October 15, 2024

Study Start

April 22, 2024

Primary Completion

April 1, 2025

Study Completion

April 22, 2025

Last Updated

October 15, 2024

Record last verified: 2024-10

Locations